Seres Therapeutics Stock Price on November 22, 2024

MCRB Stock  USD 0.97  0.05  5.43%   
If you're considering investing in Seres Stock, it is important to understand the factors that can impact its price. As of today, the current price of Seres Therapeutics stands at 0.97, as last reported on the 23rd of December, with the highest price reaching 1.00 and the lowest price hitting 0.92 during the day. Seres Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0059, which indicates the firm had a -0.0059% return per unit of risk over the last 3 months. Seres Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Seres Therapeutics' Risk Adjusted Performance of 0.0041, coefficient of variation of (16,852), and Variance of 41.37 to confirm the risk estimate we provide.
  
Seres Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0059

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsMCRB

Estimated Market Risk

 6.43
  actual daily
57
57% of assets are less volatile

Expected Return

 -0.04
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.01
  actual daily
0
Most of other assets perform better
Based on monthly moving average Seres Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Seres Therapeutics by adding Seres Therapeutics to a well-diversified portfolio.

Seres Therapeutics Valuation on November 22, 2024

It is possible to determine the worth of Seres Therapeutics on a given historical date. On November 22, 2024 Seres was worth 0.75 at the beginning of the trading date compared to the closed value of 0.77. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Seres Therapeutics stock. Still, in general, we apply an absolute valuation method to find Seres Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Seres Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Seres Therapeutics' related companies.
 Open High Low Close Volume
  0.83    0.88    0.72    0.73    4,167,572  
11/22/2024
  0.75    0.78    0.72    0.77    1,581,745  
  0.79    0.90    0.77    0.89    6,772,012  
Backtest Seres Therapeutics  |  Seres Therapeutics History  |  Seres Therapeutics Valuation   PreviousNext  
Open Value
0.75
0.77
Closing Value
20.05
Upside

Seres Therapeutics Trading Date Momentum on November 22, 2024

On November 25 2024 Seres Therapeutics was traded for  0.89  at the closing time. The top price for the day was 0.90  and the lowest listed price was  0.77 . The trading volume for the day was 6.8 M. The trading history from November 25, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 15.58% . The trading price change against the current closing price is 31.17% .

Seres Therapeutics Fundamentals Correlations and Trends

By evaluating Seres Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Seres Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Seres financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Seres Therapeutics Stock history

Seres Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Seres is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Seres Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Seres Therapeutics stock prices may prove useful in developing a viable investing in Seres Therapeutics
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. Seres Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 333 people.

Seres Therapeutics Stock Technical Analysis

Seres Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Seres Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Seres Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Seres Therapeutics Period Price Range

Low
December 23, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Seres Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Seres Therapeutics December 23, 2024 Market Strength

Market strength indicators help investors to evaluate how Seres Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Seres Therapeutics shares will generate the highest return on investment. By undertsting and applying Seres Therapeutics stock market strength indicators, traders can identify Seres Therapeutics entry and exit signals to maximize returns

Seres Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Seres Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Seres Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Seres to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Seres Stock analysis

When running Seres Therapeutics' price analysis, check to measure Seres Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seres Therapeutics is operating at the current time. Most of Seres Therapeutics' value examination focuses on studying past and present price action to predict the probability of Seres Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seres Therapeutics' price. Additionally, you may evaluate how the addition of Seres Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bonds Directory
Find actively traded corporate debentures issued by US companies
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas